Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal
Abstract
PTPRS-targeted FLS-directed therapy synergizes with TNF inhibition in therapy of arthritis.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 26, 2020
- Source ID
- 10.1126/sciadv.aba4353
Entities
People
- Anna-Karin Hultgård Ekwall
- Christian Secchi
- Christopher Barback
- Costantino Pitzalis
- Cristiano Sacchetti
- David L Boyle
- David Vera
- Dennis J. Wu
- Eugenio Santelli
- Frances Humby
- Francesco Galimi
- Fumitaka Mizoguchi
- Gary P. Sims
- Gary S Firestein
- Gyrid Nygaard
- Kamil Slowikowski
- Karen M. Doody
- Kuninobu Wakabayashi
- Martina Zoccheddu
- Mattias D Svensson
- Michael B Brenner
- Michel L. Tremblay
- Nunzio Bottini
- Piotr Mydel
- Rebecca Hands
- Rizi Ai
- Shen Yang
- Soumya Raychaudhuri
- Stephanie M. Stanford
- Tsuyoshi Kasama
- Wei Wang
Organizations
- Arthritis National Research Foundation
- AstraZeneca
- AstraZeneca (United States)
- Congressionally Directed Medical Research Programs
- Harvard Medical School
- Harvard University
- Jagiellonian University
- Karolinska Institutet
- La Jolla Institute for Allergy and Immunology
- Mass General Brigham
- McGill University
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Queen Mary University of London
- Sahlgrenska Academy
- Sahlgrenska University Hospital
- Tokyo Medical and Dental University
- University of Bergen
- University of California
- University of California, San Diego
- University of Gothenburg